NCT05158777View on ClinicalTrials.gov

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

PHASE3CompletedINTERVENTIONAL
Enrollment

2,480

Participants

Timeline

Start Date

February 13, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
Varicella
Interventions
BIOLOGICAL

Live attenuated varicella vaccines manufactured by Shanghai Institute of Biological Products Co.,Ltd.

live varicella-zoster virus in 0.5 mL of sucrose, sodium chloride, potassium chloride, sodium glutamate, phosphate and injection water per injection

BIOLOGICAL

Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd

live varicella-zoster virus in 0.5 mL of mannitol, dextrose tincture, sucrose, trehalose, human serum albumin and injection water per injection

Trial Locations (1)

Unknown

Henan Provincial Center for Disease Prevention and Control, Zhenzhou

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY